Transcranial sonography in the premotor diagnosis of Parkinson's disease

International Review of Neurobiology

Volumn 90, Issue C, 2010, Pages 93-106

  Behnke, Stefanie ^a   Schröder, Ute ^a   Berg, Daniela ^b  

^a SAARLAND UNIVERSITY   (Germany)

^b GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

Author keywords

Parkinson's disease; Premotor diagnosis; Substantia nigra hyperechogenicity; Transcranial ultrasound

Indexed keywords

6 FLUORODOPA F 18; NEUROLEPTIC AGENT;

ARTICLE; BEHAVIOR DISORDER; COGNITIVE DEFECT; DEPRESSION; DIAGNOSTIC VALUE; DYSAUTONOMIA; ECHOGRAPHY; EXTRAPYRAMIDAL SYNDROME; FAMILY HISTORY; FOLLOW UP; HUMAN; HYPOSMIA; MENTAL DISEASE; MOTOR DYSFUNCTION; NEUROLOGIC DISEASE; PARKINSON DISEASE; PARKINSONISM; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; PRIORITY JOURNAL; REM SLEEP; RISK FACTOR; SLEEP DISORDER; SUBSTANTIA NIGRA; SYMPTOM; TRANSCRANIAL SONOGRAPHY;

EID: 77955369855     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0074-7742(10)90007-X     Document Type: Chapter

References (47)

1. Abbott R.D., Petrovitch H., White L.R., Masaki K.H., Tanner C.M., Curb J.D., Grandinetti A., Blanchette P.L., Popper J.S., Ross G.W. Frequency of bowel movements and the future risk of Parkinson's disease. Neurology 2001, 57:456-462.
2. Abbott R.D., Ross G.W., White L.R., Sanderson W.T., Burchfiel C.M., Kashon M., Sharp D.S., Masaki K.H., Curb J.D., Petrovitch H. Environmental, lifestyle, and precursors of clinical Parkinson's disease: recent findings from the Honolulu-Asia Aging study. J. Neurol. 2003, 250:30-39.
3. Becker G., Seufert J., Bogdahn U., Reichmann H., Reiners K. Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography. Neurology 1995, 45:182-184.
4. Becker G., Becker T., Struck M., Lindner A., Burzer K., Retz W., Bogdahn U., Beckmann H. Reduced echogenicity of brainstem raphe specific to unipolar depression: a transcranial color-coded real-time sonography study. Biol. Psychiatry 1995, 38:180-184.
5. Becker G., Müller A., Braune S., Büttner T., Benecke R., Greulich W., Klein W., Mark G., Rieke J., Thümler R. Early diagnosis of Parkinson's disease. J. Neurol. 2002, 249:40-48.
6. Behnke S., Double K.L., Duma S., Broe G.A., Guenther V., Becker G., Halliday G.M. Substantia nigra echomorphology in the healthy very old: Correlation with motor slowing. Neuroimage 2007, 34:1054-1059.
7. Behnke S., Wollenweber F.A., Probst M., Hiry T., Schneider V., Dillmann U., Fassbender K. Substantia nigra hyperechogenicity in healthy controls: correlation with neuropsychological deficits. Mov. Disord. 2009, 24(Suppl. 1):S182.
8. Behnke S., Schroeder U., Dillmann U., Buchholz H.G., Schreckenberger M., Fuss G., Reith W., Berg D., Krick C.M. Hyperechogenicity of the substantia nigra in healthy controls is related to MRI changes and to neuronal loss as determined by f-dopa PET. Neuroimage 2009, 47:1237-1243.
9. Berendse H.W., Ponsen M.M. Detection of preclinical Parkinson's disease along the olfactory trac(t). J. Neural. Transm. 2006, 70:321-325.
10. Berg D., Becker G., Zeiler B., Tucha O., Hofmann E., Preier M., Benz P., Jost W., Reiners K., Lange K.W. Vulnerability of the nigrostriatal system as detected by transcranial ultrasound. Neurology 1999, 53:1026-1031.
11. Berg D., Supprian T., Hofmann E., Zeiler B., Jager A., Lange K.W., Reiners K., Becker T., Becker G. Depression in Parkinson's disease: Brainstem midline alteration on transcranial sonography and magnetic resonance imaging. J. Neurol. 1999, 246:1186-1193.
12. Berg D., Jabs B., Merschdorf U., Beckmann H., Becker G. Echogenicity of substantia nigra determined by transcranial ultrasound correlates with severity of parkinsonian symptoms induced by neuroleptic therapy. Biol. Psychiatry 2001, 50:463-467.
13. Berg D., Siefker C., Ruprecht-Dorfler P., Becker G. Relationship of substantia nigra echogenicity and motor function in elderly subjects. Neurology 2001, 56:13-17.
14. Berg D., Roggendorf W., Schroder U., Klein R., Tatschner T., Benz P., Tucha O., Preier M., Lange K.W., Reiners K., Gerlach M., Becker G. Echogenicity of the substantia nigra: Association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch. Neurol. 2002, 59:999-1005.
15. Braak H., Del Tredici K., Rub U., de Vos R.A., Jansen Steur E.N., Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 2003, 24:197-211.
16. Brooks D.J., Doder M. Depression in Parkinson's disease. Curr. Opin. Neurol. 2001, 14:465-470.
17. Chan-Palay V., Asan E. Quantitation of catecholamine neurons in the locus coeruleus in human brains of normal young and older adults and in depression. J. Comp. Neurol. 1989, 287:357-372.
18. De Lau L.M., Koudstaal P.J., Hofman A., Breteler M.M. Subjective complaints precede Parkinson disease: the Rotterdam study. Arch. Neurol. 2006, 63:362-365.
19. Doty R.L., Shaman P., Kimmelman C.P., Dann M.S. University of Pennsylvania Smell Identification Test: a rapid quantitative olfactory function test for the clinic. Laryngoscope 1984, 94:176-178.
20. Dujardin K., Duhamel A., Becquet E., Grunberg C., Defebvre L., Destee A. Neuropsychological abnormalities in first degree relatives of patients with familial Parkinson's disease. J. Neurol. Neurosurg. Psychiatr. 1999, 67:323-328.
21. Emre M. Dementia associated with Parkinson's disease. Lancet Neurol. 2003, 2:229-237.
22. Fearnley J.M., Lees A.J. Ageing and Parkinson's disease: Substantia nigra regional selectivity. Brain 1991, 114:2283-2301.
23. Haehner A., Hummel T., Hummel C., Sommer U., Junghanns S., Reichmann H. Olfactory loss may be a first sign of idiopathic Parkinson's disease. Mov. Disord. 2007, 22:839-842.
24. Holthoff V.A., Vieregge P., Kessler J., Pietrzyk U., Herholz K., Bönner J., Wagner R., Wienhard K., Pawlik G., Heiss W.D. Discordant twins with Parkinson's disease: positron emission tomography and early signs of impaired cognitive circuits. Ann. Neurol. 1994, 36:176-182.
25. Hornykiewicz O., Kish S.J. Biochemical pathophysiology of Parkinson's disease. Adv. Neurol. 1987, 45:19-34.
26. Iranzo A., Molinuevo J.L., Santamaría J., Serradell M., Mart M.J., Valldeoriola F., Tolosa E. Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: A descriptive study. Lancet Neurol. 2006, 5:572-577.
27. Jabs B.E., Bartsch A.J., Pfuhlmann B. Susceptibility to neuroleptic-induced parkinsonism-age and increased substantia nigra echogenicity as putative risk factors. Eur. Psychiatry 2003, 18:177-181.
28. Leentjens A.F., Van den Akker M., Metsemakers J.F., Lousberg R., Verhey F.R. Higher incidence of depression preceding the onset of Parkinson's disease: A register study. Mov. Disord. 2003, 18:414-418.
29. Lees A.J. When did Ray Kennedy's Parkinson's disease begin?. Mov. Disord. 1992, 7:110-115.
30. Liepelt I., Wendt A., Schweitzer K.J., Wolf B., Godau J., Gaenslen A., Bruessel T., Berg D. Substantia nigra hyperechogenicity assessed by transcranial sonography is related to neuropsychological impairment in the elderly population. J. Neural. Transm. 2008, 115:993-999.
31. Liepelt, I., Behnke, S., Schweitzer, K., Wolf, B., Godau, J., Wollenweber, F., Dillmann, U., Gaenslen, A., Di Santo, A., Maetzler, W., and Berg, D. (2009). Pre-motor signs of PD are related to SN hyperechogenicity assessed by TCS in an elderly population. Neurobiol. Aging (in press).
32. Markopoulou K., Larsen K.W., Wszolek E.K., Denson M.A., Lang A.E., Pfeiffer R.F., Wszolek Z.K. Olfactory dysfunction in familial parkinsonism. Neurology 1997, 49:1262-1267.
33. Muslimovic D., Post B., Speelman J.D., Schmand B. Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 2005, 65:1239-1245.
34. Ponsen M.M., Stoffers D., Twisk J.W., Wolters E., Berendse H.W. Hyposmia and executive dysfunction as predictors of future Parkinson's disease: A prospective study. Mov. Disord. 2009, 24:1060-1065.
35. Prettyman R. Extrapyramidal signs in cognitively intact elderly people. Age Ageing 1998, 27:557-560.
36. Riederer P., Wuketich S. Time course of nigrostriatal degeneration in Parkinson's disease: A detailed study of influential factors in human brain amine analogues. J. Neural Transm. 1976, 38:227-301.
37. Ross G.W., Petrovitch H., Abbott R.D., Tanner C.M., Popper J., Masaki K., Launer L., White L.R. Association of olfactory dysfunction with risk for future Parkinson's disease. Ann. Neurol. 2008, 63:167-173.
38. Ruprecht-Dorfler P., Berg D., Tucha O., Benz P., Meier-Meitinger M., Alders G.L., Lange K.W., Becker G. Echogenicity of the substantia nigra in relatives of patients with sporadic Parkinson's disease. Neuroimage 2003, 18:416-422.
39. Ruprecht-Dorfler P., Klotz P., Becker G., Berg D. Substantia nigra hyperechogenicity correlates with subtle motor dysfunction in tap dancers. Parkinsonism Relat. Disord. 2007, 13:362-364.
40. Schenck C.H., Bundlie S.R., Mahowald M.W. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder. Neurology 1996, 46:388-393.
41. Schroeder, U., Behnke, S., Buchholz, H.G., Landvogt, C., Fassbender, K., Schreckenberger, M., and Berg, D. (2010). Substantia nigra hyperechogenicity in healthy controls: A [18Fluoro] Dopa-PET Follow-up study (submitted).
42. Schweitzer K.J., Behnke S., Liepelt I., Wolf B., Grosser C., Godau J., Gaenslen A., Bruessel T., Wendt A., Abel F., Muller A., Gasser T., Berg D. Cross-sectional study discloses a positive family history for Parkinson's disease and male gender as epidemiological risk factors for substantia nigra hyperechogenicity. J. Neural Transm. 2007, 114:1167-1171.
43. Sommer U., Hummel T., Cormann K., Mueller A., Frasnelli J., Kropp J., Reichmann H. Detection of presymptomatic Parkinson's disease: Combining smell tests, transcranial sonography, and spect. Mov. Disord. 2004, 19:1196-1202.
44. Stocchi F., Vacca L., Valente M., Ruggieri S. Sleep disorders in Parkinson's disease. Adv. Neurol. 2001, 86:289-293.
45. Stockner H., Iranzo A., Seppi K., Serradell M., Gschliesser V., Sojer M., Valldeoriola F., Molinuevo J.L., Frauscher B., Schmidauer C., Santamaria J., Hogl B., Tolosa E., Poewe W. Midbrain hyperechogenicity in idiopathic REM sleep behavior disorder. Mov. Disord. 2009, 24:1906-1909.
46. Tolosa E., Compta Y., Gaig C. The premotor phase of Parkinson's disease. Parkinsonism Relat. Disord. 2007, 13:S2-S7.
47. Walter U., Hoeppner J., Prudente-Morrissey L., Horowski S., Herpertz S.C., Benecke R. Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders. Brain 2007, 130:1799-1807.